Correlation Between The9 and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both The9 and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining The9 and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The9 Ltd ADR and Spyre Therapeutics, you can compare the effects of market volatilities on The9 and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in The9 with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of The9 and Spyre Therapeutics.

Diversification Opportunities for The9 and Spyre Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between The9 and Spyre is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding The9 Ltd ADR and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and The9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The9 Ltd ADR are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of The9 i.e., The9 and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between The9 and Spyre Therapeutics

Given the investment horizon of 90 days The9 Ltd ADR is expected to generate 1.55 times more return on investment than Spyre Therapeutics. However, The9 is 1.55 times more volatile than Spyre Therapeutics. It trades about 0.39 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  879.00  in The9 Ltd ADR on August 31, 2024 and sell it today you would earn a total of  596.00  from holding The9 Ltd ADR or generate 67.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

The9 Ltd ADR  vs.  Spyre Therapeutics

 Performance 
       Timeline  
The9 Ltd ADR 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in The9 Ltd ADR are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, The9 showed solid returns over the last few months and may actually be approaching a breakup point.
Spyre Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

The9 and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with The9 and Spyre Therapeutics

The main advantage of trading using opposite The9 and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if The9 position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind The9 Ltd ADR and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements